EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

The predictive value of SOFA and APSIII scores for 28-day mortality risk in SIMI: a cohort study based on the MIMIC-IV database

Chang Liu, Hao Wang, Chenyang Liu, Min Cao

Frontiers in Cellular and Infection Microbiology · 29.07.2025 · 15

DOI: 10.3389/fcimb.2025.1574625 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 29.07.2025. Verfasst von Chang Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Organ Dysfunction Scores, Sepsis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective of this study was to systematically identify and evaluate scoring systems that predict the prognosis of patients with sepsis-induced myocardial injury (SIMI).

Methods

Data were retrieved from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. Logistic and Cox regression analyses were conducted to identify risk factors associated with 28-day mortality in patients with sepsis-induced myocardial injury (SIMI). The prognostic performance of the scoring systems was comprehensively assessed using receiver operating characteristic (ROC) curves, Kaplan-Meier survival and decision curve analysis (DCA).

Results

Logistic regression analysis showed that Acute Physiology Score III (APSIII) (Odds Ratio [OR] =1.011, 95% Confidence Interval [CI] 1.002–1.018, P=0.005), Sequential Organ Failure Assessment (SOFA) (OR =1.097, 95% CI 1.045–1.144, P<0.001), and Charlson Comorbidity Index (CHARLSON) (OR=1.095, 95% CI 1.048–1.145, P=0.036) were independent risk factors for 28-day mortality in SIMI patients. Cox regression analysis confirmed that SOFA (HR=1.082, 95% CI 1.054– 1.111, P<0.001), APSIII (HR=1.010, 95% CI 1.005–1.015, P<0.001), and CHARLSON (HR=1.044, 95% CI 1.012–1.077, P=0.007) were independent risk factors. ROC curve analysis showed that SOFA (AUC=0.685, 95% CI 0.663–0.707) and APSIII (AUC=0.683, 95% CI 0.662–0.705) had significantly higher AUC values compared to other scoring systems. DCA results showed that APSIII and SOFA had better net benefit than other scoring systems.

Conclusions

The SOFA and APSIII scores effectively identified high-risk patients with SIMI, providing evidence-based support for early clinical intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Organ Dysfunction ScoresSepsisHumansMaleFemaleAgedMiddle AgedROC CurveRisk FactorsPrognosisCohort StudiesDatabases, FactualAged, 80 and overPredictive Value of TestsKaplan-Meier EstimateIntensive Care UnitsProportional Hazards ModelsRisk Assessment

Stichwörter der Autor:innen

APSIII scoreMIMIC-IV databaseSOFA scoremortality risksepsissepsis-induced myocardial injury (SIMI)

Autor:innen und Institutionen

  • Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Zitieren

APA

Liu, C., Wang, H., Liu, C., & Cao, M. (2025). The predictive value of SOFA and APSIII scores for 28-day mortality risk in SIMI: a cohort study based on the MIMIC-IV database. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1574625

Vancouver

Liu C, Wang H, Liu C, Cao M. The predictive value of SOFA and APSIII scores for 28-day mortality risk in SIMI: a cohort study based on the MIMIC-IV database. Frontiers in Cellular and Infection Microbiology. 2025;15. doi:10.3389/fcimb.2025.1574625

BibTeX
@article{Liu2025,
  author = {Liu, Chang and Wang, Hao and Liu, Chenyang and Cao, Min},
  title = {The predictive value of SOFA and APSIII scores for 28-day mortality risk in SIMI: a cohort study based on the MIMIC-IV database},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fcimb.2025.1574625}
}
Kostenlos starten →